PMID- 18511210 OWN - NLM STAT- MEDLINE DCOM- 20080829 LR - 20161124 IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 154 IP - 3 DP - 2008 Jun 26 TI - Status epilepticus induces a TrkB to p75 neurotrophin receptor switch and increases brain-derived neurotrophic factor interaction with p75 neurotrophin receptor: an initial event in neuronal injury induction. PG - 978-93 LID - 10.1016/j.neuroscience.2008.04.038 [doi] AB - In neuronal cultures it has been demonstrated that neurotrophins can elicit neuronal death through the p75 neurotrophic receptor (p75ntr) in the absence of concomitant Trk signaling. However, it was suggested that p75ntr induces neuronal death after status epilepticus (SE) in neuronal populations that express relatively high quantities of tropomyosin receptor kinase B (TrkB). Here, using Western blot and immunohistochemistry analyses in the hippocampus, we found that 3-h SE caused a remarkable decrease in TrkB expression and phosphorylation, and a significant increase in p75ntr. TrkB modification occurs before the overexpression of the tumor suppressor protein p53, accompanies the cell damage taking place in the dentate gyrus, and precedes the CA1 neuronal injury as assessed by Fluoro-Jade B and Nissl staining. Co-immunoprecipitation of brain-derived neurotrophic factor (BDNF) or its immature form proBDNF showed increased interaction with p75ntr after its binding to TrkB was reduced. Interestingly, proBDNF also increases its binding with p75ntr after seizures that do not cause neuronal death (animals injected with pilocarpine that fail to enter SE). However, in those animals, TrkB protein levels remained unchanged and its phosphorylation increased. Our results indicate an intrinsic capacity of neurons in vivo to modify final neurotrophin output by changing the proportion of their receptors' expression and the receptors' interaction with their ligands. These early events support the idea that neurotrophins may be involved in the induction of neuronal death in vivo under pathological conditions. FAU - Unsain, N AU - Unsain N AD - Laboratorio de Neurobiologia, Centro de Biologia Celular y Molecular, Catedra de Biologia Celular, Facultad de Ciencias Exactas, Fisicas y Naturales, Universidad Nacional de Cordoba, Av. Velez Sarsfield 1611, X5016 GCA, Cordoba, Argentina. FAU - Nunez, N AU - Nunez N FAU - Anastasia, A AU - Anastasia A FAU - Masco, D H AU - Masco DH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080502 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Benzoxazines) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Coloring Agents) RN - 0 (Fluoresceins) RN - 0 (Muscarinic Agonists) RN - 0 (Organic Chemicals) RN - 0 (Oxazines) RN - 0 (Receptor, Nerve Growth Factor) RN - 0 (fluoro jade) RN - 01MI4Q9DI3 (Pilocarpine) RN - 2AB49C465R (cresyl violet) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Animals MH - Benzoxazines MH - Blotting, Western MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Coloring Agents MH - Electroshock MH - Fluoresceins MH - Immunohistochemistry MH - Immunoprecipitation MH - In Situ Nick-End Labeling MH - Male MH - Muscarinic Agonists MH - Neurons/*pathology MH - Organic Chemicals MH - Oxazines MH - Pilocarpine MH - Rats MH - Rats, Wistar MH - Receptor, Nerve Growth Factor/*metabolism MH - Receptor, trkB/*metabolism MH - Status Epilepticus/chemically induced/*metabolism/*pathology EDAT- 2008/05/31 09:00 MHDA- 2008/08/30 09:00 CRDT- 2008/05/31 09:00 PHST- 2007/09/11 00:00 [received] PHST- 2008/04/03 00:00 [revised] PHST- 2008/04/04 00:00 [accepted] PHST- 2008/05/31 09:00 [pubmed] PHST- 2008/08/30 09:00 [medline] PHST- 2008/05/31 09:00 [entrez] AID - S0306-4522(08)00567-8 [pii] AID - 10.1016/j.neuroscience.2008.04.038 [doi] PST - ppublish SO - Neuroscience. 2008 Jun 26;154(3):978-93. doi: 10.1016/j.neuroscience.2008.04.038. Epub 2008 May 2.